Newsroom

BigHat closes oversubscribed seed round

Read more

BigHat announces the closing of its oversubscribed seed round, led by 8VC and joined by AME Cloud Ventures and Innovation Endeavors.

‍

Posted:

10/22/2019

Read Time:

mins

Words by:

BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics

BigHat’s Next Chapter: A Message from CEO Peyton Greenside

Lonza’s Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC

BigHat featured on Genetic Engineering & Biotechnology News

BigHat named to the 2024’s Fierce Biotech 15

BigHat’s Cofounder and CSO, Peyton Greenside, Joins the Timmerman Traverse for Sickle Forward

BigHat Biosciences Enters into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design

BigHat’s CIO on Software Engineering Daily podcast

AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies

BigHat on Genetic Engineering & Biotechnology News

BigHat’s CSO on Biocom CA’s Lifelines Podcast

BigHat’s CSO presents at Antibody Engineering and Therapeutics Conference Europe 2023